• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核基质蛋白22检测及尿细胞学检查在上尿路尿路上皮肿瘤中的诊断价值

Diagnostic value of the nuclear matrix protein 22 test and urine cytology in upper tract urothelial tumors.

作者信息

Jovanovic M, Soldatovic I, Janjic A, Vuksanovic A, Dzamic Z, Acimovic M, Hadzi-Djokic J

机构信息

Urology Clinic, Clinical Center of Serbia, Belgrade, Serbia.

出版信息

Urol Int. 2011;87(2):134-7. doi: 10.1159/000330246. Epub 2011 Aug 24.

DOI:10.1159/000330246
PMID:21865670
Abstract

OBJECTIVE

To investigate the diagnostic value of the nuclear matrix protein 22 (NMP22) test in comparison to urine cytology for the detection of upper tract urothelial carcinoma.

PATIENTS AND METHODS

Patients with transitional cell carcinoma of the upper urinary tract (n = 34) and patients with renal calculosis (n = 25) were included in this study. Voided urine samples and separated catheter urine specimens were assayed for NMP22 and cytological examination.

RESULTS

The sensitivity of the NMP22 test in separated and voided urine was 73.2 and 70.5%, respectively, compared to 64.7 and 58.8% of urine cytology. The specificity of the NMP22 test in separated and voided urine was 88 and 92%, respectively, compared to 96 and 96% of urine cytology. The combination of separated and voided urine is the best method because the sensitivity is 79.41% and specificity 88%. There is a high agreement of the NMP22 test in voided and separated urine (kappa = 0.795, p < 0.01), indicating that the voided urine is adequate for diagnosis.

CONCLUSIONS

The NMP22 test has higher sensitivity but lower specificity than cytology. The combination of these two tests could be a very useful diagnostic method for detection of upper urothelial tumors.

摘要

目的

比较核基质蛋白22(NMP22)检测与尿细胞学检查对上尿路尿路上皮癌的诊断价值。

患者与方法

本研究纳入了34例上尿路移行细胞癌患者和25例肾石病患者。对晨尿样本和导尿分离样本进行NMP22检测及细胞学检查。

结果

NMP22检测对导尿分离样本和晨尿样本的敏感性分别为73.2%和70.5%,而尿细胞学检查的敏感性分别为64.7%和58.8%。NMP22检测对导尿分离样本和晨尿样本的特异性分别为88%和92%,而尿细胞学检查的特异性分别为96%和96%。导尿分离样本和晨尿样本联合检测是最佳方法,其敏感性为79.41%,特异性为88%。NMP22检测在晨尿样本和导尿分离样本中的一致性较高(kappa = 0.795,p < 0.01),表明晨尿样本足以用于诊断。

结论

NMP22检测的敏感性高于细胞学检查,但特异性较低。这两种检测方法联合应用可能是检测上尿路尿路上皮肿瘤非常有用的诊断方法。

相似文献

1
Diagnostic value of the nuclear matrix protein 22 test and urine cytology in upper tract urothelial tumors.核基质蛋白22检测及尿细胞学检查在上尿路尿路上皮肿瘤中的诊断价值
Urol Int. 2011;87(2):134-7. doi: 10.1159/000330246. Epub 2011 Aug 24.
2
Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.核基质蛋白、纤连蛋白、膀胱癌抗原及晨尿细胞学检查在膀胱肿瘤检测中的比较评估
J Urol. 2002 Aug;168(2):465-9.
3
Cytokeratin-20 immunocytochemistry in voided urine cytology and its comparison with nuclear matrix protein-22 and urine cytology in the detection of urothelial carcinoma.尿脱落细胞学中细胞角蛋白-20免疫细胞化学及其在检测尿路上皮癌中与核基质蛋白-22和尿细胞学的比较。
Diagn Cytopathol. 2012 Sep;40(9):755-9. doi: 10.1002/dc.21617. Epub 2011 Jan 6.
4
Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer.尿NMP22膀胱检测在浅表性膀胱癌诊断中的应用
Eur Urol. 2005 Dec;48(6):951-6; discussion 956. doi: 10.1016/j.eururo.2005.09.002. Epub 2005 Sep 26.
5
Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology.通过尿核基质蛋白22和细胞学检查对膀胱肿瘤复发、分期及分级进行风险分层。
Eur Urol. 2004 Mar;45(3):304-13; author reply 313. doi: 10.1016/j.eururo.2003.10.020.
6
Prognostic value of cytology, nuclear matrix protein 22 (NMP22) test, and urinary bladder cancer II (UBC II) test in early recurrent transitional cell carcinoma of the bladder.细胞学、核基质蛋白22(NMP22)检测及膀胱癌II(UBC II)检测在膀胱早期复发性移行细胞癌中的预后价值。
Ann Clin Lab Sci. 2006 Winter;36(1):31-8.
7
Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.NMP22膀胱检测试验与尿液细胞学检查在复发性膀胱癌检测中的比较。
Jpn J Clin Oncol. 2006 Mar;36(3):172-5. doi: 10.1093/jjco/hyi244. Epub 2006 Mar 6.
8
Comparison of the sensitivity and specificity of urine cytology, urinary nuclear matrix protein-22 and multitarget fluorescence in situ hybridization assay in the detection of bladder cancer.尿液细胞学检查、尿核基质蛋白-22及多靶点荧光原位杂交检测法在膀胱癌检测中的敏感性和特异性比较
Scand J Urol Nephrol. 2011 Mar;45(2):113-21. doi: 10.3109/00365599.2010.533694. Epub 2010 Nov 22.
9
Validation of the diagnostic value of NMP22 BladderChek test as a marker for bladder cancer by photodynamic diagnosis.通过光动力诊断验证NMP22膀胱检测作为膀胱癌标志物的诊断价值。
Eur Urol. 2007 Feb;51(2):403-7; discussion 407-8. doi: 10.1016/j.eururo.2006.08.001. Epub 2006 Aug 15.
10
Detection of recurrent bladder cancer: NMP22 test or urine cytology?复发性膀胱癌的检测:NMP22检测还是尿细胞学检查?
Urol J. 2012 Winter;9(1):367-72.

引用本文的文献

1
Diagnostic status and new explorations in upper urinary tract urothelial carcinoma: a literature review.上尿路尿路上皮癌的诊断现状与新探索:文献综述
Transl Androl Urol. 2024 Nov 30;13(11):2570-2586. doi: 10.21037/tau-24-326. Epub 2024 Nov 28.
2
Non-Invasive Biomarkers in the Diagnosis of Upper Urinary Tract Urothelial Carcinoma-A Systematic Review.非侵入性生物标志物在上尿路尿路上皮癌诊断中的系统评价
Cancers (Basel). 2022 Mar 16;14(6):1520. doi: 10.3390/cancers14061520.
3
Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma.
后腹腔镜肾输尿管全长切除术治疗上尿路尿路上皮癌术后膀胱内复发的危险因素分析。
BMC Urol. 2021 Dec 2;21(1):167. doi: 10.1186/s12894-021-00932-2.
4
An ensemble approach of urine sediment image analysis and NMP22 test for detection of bladder cancer cells.一种用于检测膀胱癌细胞的尿沉渣图像分析与NMP22检测的综合方法。
J Clin Lab Anal. 2020 Aug;34(8):e23345. doi: 10.1002/jcla.23345. Epub 2020 Jul 10.
5
Use of the Nuclear Matrix Protein 22 BladderChek Test for the Detection of Primary and Recurrent Urothelial Carcinoma.核基质蛋白 22 膀胱 Chek 测试在原发性和复发性尿路上皮癌检测中的应用。
Dis Markers. 2020 May 8;2020:3424039. doi: 10.1155/2020/3424039. eCollection 2020.
6
Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma.尿液游离 DNA 中 TERT 启动子和 FGFR3 突变在上尿路尿路上皮癌中的诊断潜能。
Cancer Sci. 2019 May;110(5):1771-1779. doi: 10.1111/cas.14000. Epub 2019 Apr 7.
7
Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?尿液标志物对上尿路尿路上皮癌检测的性能:上尿路尿液比膀胱尿液更准确吗?
Dis Markers. 2018 Jan 30;2018:5823870. doi: 10.1155/2018/5823870. eCollection 2018.
8
The role of urinary cytology when diagnostic workup is suspicious for upper tract urothelial carcinoma but tumour biopsy is nonconfirmatory.当诊断检查怀疑为上尿路尿路上皮癌但肿瘤活检未能确诊时,尿液细胞学检查的作用。
Can Urol Assoc J. 2017 Jul;11(7):E285-E290. doi: 10.5489/cuaj.4150. Epub 2017 Jul 11.
9
Physical inactivity and low fitness deserve more attention to alter cancer risk and prognosis.身体活动不足和体能不佳值得更多关注,以改变癌症风险和预后。
Cancer Prev Res (Phila). 2015 Feb;8(2):105-10. doi: 10.1158/1940-6207.CAPR-14-0320. Epub 2014 Nov 21.
10
[Urine cytology - update 2013. A systematic review of recent literature].[尿液细胞学——2013年更新。近期文献的系统评价]
Urologe A. 2013 Sep;52(9):1207-24. doi: 10.1007/s00120-013-3301-7.